THEMAVEN, INC. (OTCMKTS:MVEN) Files An 8-K Entry into a Material Definitive Agreement

0

THEMAVEN, INC. (OTCMKTS:MVEN) Files An 8-K Entry into a Material Definitive Agreement
Item 1.01 Entry Into a Material Definitive Agreement.

The disclosure under Item 3.02 and 8.01 is incorporated herein by reference to the extent required.

Item 3.02 Unregistered Sales of Equity Securities.

On January 4, 2018, theMaven,Inc. (the “Company”) accepted a subscription on a securities purchase agreement (the “Purchase Agreement”) with a purchaser (the “Investor”), for the sale by the Company of an aggregate of 1,200,000 shares of common stock of the Company, par value $0.01 per share (the “Common Stock”), at a price of $2.50 per share (the “Offering”). The net proceeds after estimated issuance costs are approximately $2,950,000.

The Company issued to MDB Capital Group LLC (the “Placement Agent”), in consideration for its services as placement agent for the Offering, 60,000 shares of Common Stock and 60,000 Warrants to purchase Common Stock at $2.50 per share.

to the Purchase Agreement, the Company has agreed to indemnify the Investor for liabilities arising out of or relating to (i)any breach of any of the representations, warranties, covenants or agreements made by the Company in the Purchase Agreement or related documents or (ii)any action instituted against an Investor with respect to the Offering, subject to certain exceptions. The Purchase Agreement also contains customary representations and warranties and covenants of the Company and was subject to customary closing conditions.

In addition, the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with the Investors, dated January 4, 2018, to which the Company agreed to register for resale the shares of Common Stock purchased to the Purchase Agreement. The Company also is committed to register the 60,000 shares issued to the Placement Agent. The Company has committed to file the registration statement no later than 200 days after the Closing and to cause the registration statement to become effective no later than the earlier of (i)seven business days after the SEC informs the Company that no review of the registration statement will be made or that the SEC has no further comments on the registration statement. The Registration Rights Agreement provides for liquidated damages upon the occurrence of certain events, including the Company’s failure to file the registration statement or cause it to become effective by the deadlines set forth above. The amount of liquidated damages payable to an Investor would be 1% of the aggregate amount invested by such Investor for each 30-day period, or pro rata portion thereof, during which the default continues, up to a maximum amount of 5.0% of the aggregate amount invested by an Investor to the Purchase Agreement or the value of the securities registered by the Placement Agent.

The shares of Common Stock issued in the Offering and to Placement Agent were offered and sold exclusively to accredited investors in a transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), as a transaction not involving a public offering, to Section4(a)(2)of the Securities Act and Rule506 of Regulation D promulgated thereunder. The Investors and the Placement Agent represented their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends were placed upon the stock certificates and Agent Warrant issued at the Closing. The offer and sale of the securities were made without any general solicitation or advertising.

The foregoing summaries of the Purchase Agreement, the Registration Rights Agreement and the Agent Warrant are qualified in their entirety by reference to the full text of the agreements, which are attached as Exhibits 10.1 and 10.2 hereto and are incorporated herein by reference.

On January 4, 2017, TheMaven, Inc. (“Maven”) entered into a non-binding letter of intent to acquire privately held HubPages, Inc. (“HubPages”), a digital media company that operates a network of 27 premium content channels around topics of passion (the “Letter of Intent”). The acquisition will be subject to negotiation and execution of definitive documentation and various conditions precedent. The parties expect to complete acquisition documentation, employment agreements and other ancillary agreements and satisfy the closing conditions in approximately three months.

The consideration payable for the acquisition to HubPages’ consists of the following: (a) the equity stockholders and common stock option holders with vested rights will be paid an aggregate of $5.0 million in cash, (b) the common stockholders will be issued an aggregate of $4.250 million short-term, secured promissory notes due 90 days after closing, and (c) 2.4 million common shares of the Maven will be issued to the holders of unvested common stock options of the HubPages. At closing $750,000 will be placed into an indemnity escrow for twelve months, to be released to the common stockholders of the HubPages. The 2.4 million shares of Maven stock will be issued under restricted stock agreements that will start vesting 13 months after the closing until 36 months after the closing, so long as the recipient is employed by the Maven on the vesting dates. The total number of shares of the equity consideration will be subject to adjustment if HubPages has less than 31,500,000 total unique users in the month immediately prior to closing and will be subject to repurchase at a nominal amount if the average monthly unique users on the HubPages web page for all of 2018 is less than the forgoing user number. Some of the equity consideration also will be subject to general indemnity claims by the Maven. The Maven has committed to issuing up to a maximum of 2.4 million additional shares of common stock if the recipients of the equity consideration, if and when they sell their equity after vesting during the 36 months after closing, if the sales price achieved is less than $2.50. The Maven has a right of first refusal at the greater of the 30-day trailing average price of $2.50 on any of the equity consideration that a recipient intends to sell for 36 months after the closing.

Item 9.01 Financial Statements and Exhibits.
99.1 Press release dated January 5, 2018


theMaven, Inc. Exhibit
EX-10.1 2 tv482764_ex10-1.htm EXHIBIT 10.1   Exhibit 10.1   SECURITIES PURCHASE AGREEMENT   This SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of the ____ day of _________ 2017,…
To view the full exhibit click here

About THEMAVEN, INC. (OTCMKTS:MVEN)

theMaven, Inc., formerly Integrated Surgical Systems, Inc., is a development-stage company. The Company is engaged in developing a network of professionally managed online media channels, with an underlying technology platform. The Company offers theMaven platform, which is a group media network featuring content across multiple content segments. The Company’s platform provides value to independent publishers through distribution; engagement for their content and community; monetization through a range of advertising partnerships and membership programs, and tools to manage their audience and growth. It focuses on operating each channel by a Channel Partner drawn from subject matter experts, reporters, group evangelists and social leaders. The Company operates a Website at themaven.net. It focuses on incorporating mobile, video, communications, social, notifications and other technology into its theMaven platform, including DevOps processes and a cloud-based back-end.